Literature DB >> 12161813

The reverse transcriptase sequence of human immunodeficiency virus type 1 is under positive evolutionary selection within the central nervous system.

Kelly J Huang1, Gerald M Alter, Dawn P Wooley.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) enters the central nervous system (CNS) during the acute phase of infection and causes AIDS-related encephalitis and dementia in 30% of individuals. Previous studies show that HIV-1 sequences derived from the CNS of infected patients, including the sequence encoding reverse transcriptase (RT), are genetically distinct from sequences in other tissues. The hypothesis of the current study is that the RT sequence of HIV-1 is under positive selection within the CNS. Multiple alignments of non-CNS-derived and CNS-derived HIV-1 RT sequences were constructed using the ClustalW 1.8 program. The multiple alignments were analyzed with the Synonymous/Nonsynonymous Analysis Program. Codon positions 122-125, 135-149, and 166-212 of the CNS-derived RT sequences underwent a greater accumulation of nonsynonymous than synonymous substitutions, which was markedly different from the analysis results of the non-CNS-derived RT sequences. These residues are located in the finger and palm subdomains of the RT protein structure, which encodes the polymerase active site. The analysis of CNS-derived partial-length RT sequences that encompass these regions yielded similar results. A comparison of CNS-derived RT sequences to a non-CNS-derived RT consensus sequence revealed that a majority of the nonsynonymous substitutions resulted in a specific amino acid replacement. These results indicate that reverse transcriptase is under positive selection within the CNS. The amino acid replacements were visualized on a three-dimensional structure of HIV-1 RT using the Sybyl software suite. The protein structure analysis revealed that the amino acid replacements observed among the CNS-derived sequences occurred in areas of known structural and functional significance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161813     DOI: 10.1080/13550280290100716

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  51 in total

1.  Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.

Authors:  P H Cunningham; D G Smith; C Satchell; D A Cooper; B Brew
Journal:  AIDS       Date:  2000-09-08       Impact factor: 4.177

2.  Coupling ribose selection to fidelity of DNA synthesis. The role of Tyr-115 of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  C E Cases-Gonzalez; M Gutierrez-Rivas; L Ménendez-Arias
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

3.  Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism.

Authors:  J M Strizki; A V Albright; H Sheng; M O'Connor; L Perrin; F González-Scarano
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  Uniquely altered DNA replication fidelity conferred by an amino acid change in the nucleotide binding pocket of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  D A Lewis; K Bebenek; W A Beard; S H Wilson; T A Kunkel
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

5.  Molecular architecture of the mutagenic active site of human immunodeficiency virus type 1 reverse transcriptase: roles of the beta 8-alpha E loop in fidelity, processivity, and substrate interactions.

Authors:  K K Weiss; S J Isaacs; N H Tran; E T Adman; B Kim
Journal:  Biochemistry       Date:  2000-09-05       Impact factor: 3.162

6.  Brain-derived HIV-1 tat sequences from AIDS patients with dementia show increased molecular heterogeneity.

Authors:  A C Bratanich; C Liu; J C McArthur; T Fudyk; J D Glass; S Mittoo; G A Klassen; C Power
Journal:  J Neurovirol       Date:  1998-08       Impact factor: 2.643

7.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

8.  Clinical-neuropathologic correlation in HIV-associated dementia.

Authors:  J D Glass; S L Wesselingh; O A Selnes; J C McArthur
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

9.  Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance.

Authors:  H Huang; R Chopra; G L Verdine; S C Harrison
Journal:  Science       Date:  1998-11-27       Impact factor: 47.728

10.  HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies.

Authors:  L G Epstein; C Kuiken; B M Blumberg; S Hartman; L R Sharer; M Clement; J Goudsmit
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

View more
  6 in total

Review 1.  Genetic variation and HIV-associated neurologic disease.

Authors:  Satinder Dahiya; Bryan P Irish; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

2.  Bioinformatic analysis of neurotropic HIV envelope sequences identifies polymorphisms in the gp120 bridging sheet that increase macrophage-tropism through enhanced interactions with CCR5.

Authors:  Megan E Mefford; Kevin Kunstman; Steven M Wolinsky; Dana Gabuzda
Journal:  Virology       Date:  2015-03-20       Impact factor: 3.616

Review 3.  Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant?

Authors:  Guido van Marle; Christopher Power
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

Review 4.  HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment.

Authors:  Serena Spudich; Francisco González-Scarano
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

5.  HIV Drug Resistance Mutations in Patients with HIV and HIV-TB Coinfection After Failure of First-Line Therapy: A Prevalence Study in a Resource-Limited Setting.

Authors:  Nawaid Hussain Khan; Mikashmi Kohli; Kartik Gupta; Bimal Kumar Das; Ravindra Mohan Pandey; Sanjeev Sinha
Journal:  J Int Assoc Provid AIDS Care       Date:  2019 Jan-Dec

6.  Evolution of infectious bronchitis virus in Taiwan: positively selected sites in the nucleocapsid protein and their effects on RNA-binding activity.

Authors:  Shu-Ming Kuo; Hsiao-Wei Kao; Ming-Hon Hou; Ching-Ho Wang; Siou-Hong Lin; Hong-Lin Su
Journal:  Vet Microbiol       Date:  2012-10-29       Impact factor: 3.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.